Phelix Research and Development

Phelix Research and Development is a private, London-based contract research organization specializing in diagnostics development services. As a service provider, its business model is based on generating revenue through contracted research, placing it in the 'Revenue Generating' category without a traditional therapeutic pipeline of its own. The company's success is tied to the broader outsourcing trends in the biopharma industry, particularly in the complex and growing diagnostics sector, where it helps clients navigate preclinical and clinical regulatory pathways.

Integrated service capabilities for diagnostics development, including assay development, analytical/clinical validation, regulatory strategy, and clinical trial management for IVDs and companion diagnostics.

Phelix competes in the crowded CRO market, facing large global firms (e.g., IQVIA, LabCorp) with broad resources and smaller specialized agencies. Its differentiation hinges on deep expertise in the specific regulatory and clinical pathways for diagnostic products.